Doç.Dr. İLKER TİNAY
Tıp Fakültesi / Cerrahi Tıp Bilimleri Bölümü

E-Posta
Onay Verilmemiş
Telefon
Onay Verilmemiş
Adres
Marmara Üniversitesi - Tıp Fakültesi / Cerrahi Tıp Bilimleri Bölümü / Oda No (Belirtilmemiş)
Web Adresi
Belirtilmemiş

PROJELER & PATENTLER

PROJELER
ULUSAL
-TÜBİTAK 1005
2016 - 2018
Araştırmacı
''215E058 - İdrarda En 2 Proteini Duzeyini BelirlemeyeYönelik Mems Tabanlı Bir Biyosensör Prototipi Tasarım Ve Gerçeklenmesi''
YÜKSEKÖĞRETİM KURUMLARI TARAFINDAN DESTEKLİ BİLİMSEL ARAŞTIRMA PROJESİ
2014 - 2017
Araştırmacı
''Pelvis ışınlamalarına bağlı erektil disfonksiyon ve infertiliteye karşı resveratrol tedavisinin olası koruyucu etkilerinin incelenmesi''
ULUSLARARASI
DİĞER (ULUSLARARASI)
2013 - 2014
Araştırmacı
''A Randomized Double Blind Multi Centre Study to Evaluate the Efficacy and Safety of Adding Mirabegron to Solifenacin in Incontinent OAB Subjects Who Have Received Solifenacin for 4 Weeks and Warrant Additional Relief for Their OAB Symptoms BESIDE NCT01908829 ''
2012 - Halen
Yürütücü
''Phase 3 A Randomized Double blind Comparative Study of ZYTIGA Abiraterone Acetate Plus Low dose Prednisone Plus Androgen Deprivation Therapy ADT Versus ADT Alone in Newly Diagnosed Subjects With High Risk Metastatic Hormone Naive Prostate Cancer mHNPC NCT01715285 ''
2012 - 2013
Araştırmacı
''A Study to Evaluate the Efficacy and Safety of Mirabegron Compared toSolifenacin in Patients With Overactive Bladder Who Are Previously Treated With Another Medicine But Were Not Satisfied With That Treatment BEYOND NCT01638000 ''
2007 - 2010
Araştırmacı
''A Phase II study exploring the Dose Dependent Response to Three Dose LEvels of BOTOX in Patients with Urinary Incontinence Due to Neurogenic Detrusor Overactivity NCT00575016 ''
2007 - 2012
Araştırmacı
''A Multicenter Randomized Double blind Study Comparing the Efficacy and Safety of VEGF Trap Versus Placebo Administered every 3 Weeks in Patients Treated with Docetaxel Prednisone for Metastatic Androgen Independent Prostate Cancer VENICE NCT00519285 ''
2006 - 2012
Araştırmacı
''A Randomized Double Blind Multicenter Study of Denosumab Compared WithZoledronic Acid Zometa in the Treatment of Bone Metastases in Men with Hormone Refractory Prostate Cancer NCT00321620 ''
2006 - 2010
Araştırmacı
''Adjuvant Leuprolide With or Without Docetaxel in High Risk Prostate Cancer After Radical Prostatectomy NCT00283062 ''
2006 - 2007
Araştırmacı
''A Randomized Double Blind Placebo Controlled Detrol LA Add On To Alpha Blocker Study In Men With Persistent Overactive Bladder Symptoms Of Urinary Frequency And Urgency with without Urgency Incontinence After Previous Monotherapy With Alpha Blocker NCT00282932 ''
2003 - 2009
Araştırmacı
''A Randomized Double Blind Placebo Controlled Parallel Group Study of the Efficacy and Safety of Dutasteride 0 5mg Administered Once Daily for Four Years to Reduce the Risk of Biopsy Detectable Prostate Cancer REDUCE NCT00056407 ''
PATENTLER
Henüz içerik girilmemiş.